British Pharmacopoeia. 2012a. The British Pharmacopoeia Commission. http://www.pharmacopoeia.gov.uk/the-british-pharmacopoeia-commission.php (accessed November 16, 2012).

———. 2012b. Monograph development. http://www.pharmacopoeia.gov.uk/monographs/monograph-development.php (accessed November 8, 2012).

———. 2012c. Quinine sulfate capsules. In British pharmacopoeia volume III: Formulated preparations—specific monographs. http://bp2012.infostar.com.cn/Bp2012.aspx?tab=browse&a=display&n=1002&id=5400 (accessed March 5, 2013).

Brockbank, W. 1964. Sovereign remedies: A critical depreciation of the 17th century London pharmacopoeia. Medical History 8(1):1-14.

Carpenter, D. 2010. Reputation and power: Organizational image and pharmaceutical regulation at the FDA. Princeton, NJ: Princeton University Press.

Carpenter, D., and D. Tobbell. 2011. Bioequivalence: The regulatory career of a pharmaceutical concept. Bulletin of the History of Medicine 85(1):91-131.

CASCADE Collaboration. 2003. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362(9392):1267-1274.

CDC (Centers for Disease Control and Prevention). 2013. Multistate fungal meningitis outbreak—current case count. http://www.cdc.gov/hai/outbreaks/meningitis-map-large.html (accessed January 28, 2013).

Chan, M. 2012. Opening remarks at the first meeting of the Member State Mechanism on Substandard/Spurious/Falsely-Labelled/Falsified/Counterfeit Medical Products. Buenos Aires, Argentina: The World Health Organization.

Clift, C. 2010. Combating counterfeit, falsified and substandard medicines: Defining the way forward? London, UK: Chatham House (Royal Institute of International Affairs).

Council of Europe. 2011. Council of Europe Convention on the Counterfeiting of Medical Products and Similar Crimes Involving Threats to Public Health. http://conventions.coe.int/Treaty/EN/Treaties/Html/211.htm (accessed April 26, 2012).

———. 2013. European Pharmacopoeia members and European Pharmacopoeia observers. http://www.edqm.eu/en/List-of-PhEur-Members-Observers-1023.html (accessed January 8, 2013).

Daermmrich, A. 2003. Regulatory laws and political culture in the United States and Germany. In Regulation of the pharmaceutical industry, edited by J. Abraham and H. L. Smith. Hampshire, UK: Palgrave Macmillan.

ECHAMP (European Coalition on Homeopathic and Anthrophosophic Medicinal Products). 2012. Regulation of pharmaceuticals in the EU. http://www.echamp.eu/regulation.html (accessed November 28, 2012).

Economist. 2001. Tripping up on cheaper drugs. June 22.

———. 2012. Bad medicine. October 13. http://www.economist.com/node/21564546 (accessed May 1, 2013).

EDQM (European Directorate for the Quality of Medicines & Healthcare). 2012. European Directorate for the Quality of Medicines & Healthcare. Strasbourg, France: EDQM.

EMA (European Medicines Agency). 2012. Falsified medicines. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000186.jsp&mid=WC0b01ac058002d4e8&jsenabled=true (accessed May 1, 2012).

European Pharmacopoeia. 2012. European Pharmacopoeia online. http://online.edqm.eu/EN/entry.htm (accessed November 16, 2012).

FDA (U.S. Food and Drug Administration). 2010. FDA basics: When and why was FDA formed? http://www.fda.gov/AboutFDA/Transparency/Basics/ucm214403.htm (accessed November 19, 2012).

———. 2012a. Counterfeit medicine. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/CounterfeitMedicine/default.htm (accessed March 12, 2012).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement